A total of 125 KEGG pathways were significantly enriched, and the top 10 results (Figure 3B) included pathways in cancer (hsa05200), prostate cancer (hsa05215), small cell lung cancer (hsa05222), colorectal cancer (hsa05210), aldosterone-regulated sodium reabsorption (hsa04960), VEGF signaling pathway (hsa04370), focal adhesion (hsa04510), thyroid cancer (hsa05216), toxoplasmosis (hsa05145), and PPAR signaling pathway (hsa03320). This evidence concerns the gene VEGFA and prostate cancer.